Dr Reddy's Labs expects stronger growth from US market

Reacting on the numbers in the press conference, company's vice chairman and CEO GV Prasad said that it was a good quarter in terms of growth; the company grew by 18%, reports CNBC-TV18’s Ekta Batra.

July 20, 2011 / 18:41 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Dr Reddy's Labs has reported a 21.5% fall in its first quarter FY12 net profit to Rs 263 crore against Rs 335 crore in the year ago period, as per IFRS. Net sales too declined nearly 2% to Rs 1,978 crore from Rs 2,017 crore year-on-year. Its bottomline was way below expectations while topline was in-line. Its EBITDA margin grew by 14%, lower as compared to 15.6% growth in same quarter the previous year.

Also read: Dr Reddy's Labs Q1 net profit down 21.5% at Rs 263 crore Reacting on the numbers in the press conference, company
first published: Jul 20, 2011 06:02 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!